Org224283

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOrg224283
Drug Alias NameOrg224283
ClassificationSmall molecules
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonistsThrombin inhibitorsFactor Xa inhibitors
TargetsCoagulation factor XProthrombinIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued
Highest Status in ChinaN/A
Originator CompaniesOrganon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrganonEndotis Pharma SA
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A